A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational ...

The NHS’ long term survival is at stake – the Ten Year Plan demonstrates the government’s commitment to invest in its recovery, but in order to truly tackle the existential issues at the heart of the ...

Next-generation sequencing (NGS) generates comprehensive and actionable information on molecular tumour profiles. But despite recommendations for the use of NGS in lung cancer, and support for its ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...

Hidradenitis Suppurativa (HS) has a significant impact on the wellbeing of people living with the condition, the National Health Service (NHS), and broader society, but HS and its range of impacts are ...

In this report, we propose a novel payment model that will incentivise broader value demonstration for diagnostics for antibiotics that could inform longer-term financing and reimbursement ...

In this report, we describe the design of a globally aligned, value-based, fully-delinked pull incentive, where payers provide manufacturers with a pre-specified subscription fee based on the value of ...

These therapies are particularly effective for chronic conditions, which require long-term treatment. In this report, we primarily focus on injectable therapies that have durations of action and ...

This is the second in our series of Insights considering the implications of President Trump’s Executive Order on ‘Most Favoured Nation’ drug pricing. We know that pegging US drug prices to the rest ...

As healthcare systems outside of the US strive to allocate resources efficiently, the use of economic evaluation metrics like Quality-Adjusted Life Years (QALYs) has become increasingly common. QALYs ...

Addressing a critical gap in AMR policy and evaluation Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and impose economic costs exceeding ...